The Founder at the Prostate Seed Institute explains the determination of the prostate cancer risk group.
Irving, Texas, - When oncologists diagnose one for prostate cancer, they may need more details, other than just confirmation, to recommend suitable treatment. A common way that doctors use to determine prostate cancer’s aggressiveness is to assign it a Prostate Cancer Risk Group. The groups usually indicate the possibility of the disease spreading and how fast that could happen.
“Using risk groups, we can determine the type of treatment or possibly a combination of treatments that may suit a particular patient,” states the Founder. “So, without these risk groups, merely confirming that one has prostate cancer isn’t enough to suggest the best treatment.”
The three main factors that oncologists use to determine a patient’s Prostate Cancer Group include:
• Prostate Specific Antigen test results – The blood test can give useful information regarding the prostate’s health. The presence of prostate cancer is confirmed by a higher secretion ofthis antigen and this can be measured in the patient’s blood samples. The test can also be used in the screening of prostate cancer.
• The Gleason Score – It’s obtained after a biopsy of prostate tissues. A pathologist views the samples under the microscope to see the cells. A higher Gleason Score indicates a greater cancer risk.
• Prostate Cancer Stage –To stage prostate cancer, one should analyze one or more tests. A stage involves the progression of the disease in the gland and any other possible spread. When the cancer is in early stages, it’s confined to the prostate gland. If it has spread to areas beyond the gland, it will be graded at an advanced stage.
“Before making suitable treatment recommendations, the doctor will first need to understand the risk a tumor might pose,” explains The Founder. One way to achieve this is by carrying out the appropriate tests for assigning a patient to a certain Prostate Cancer Risk Group.”
To receive proper diagnosis and to identifyyour Prostate Cancer Risk Group to receive suitable treatment, the oncologists at the Prostate Seed Institute are ready to help.
